By Gary Curhan, MD, CMO, OM1 Real-world data (RWD) can be used to find appropriate patients for observational studies and clinical trials, but for study eligibility, clinicians and researchers need details not found in claims. Using heart failure with preserved ejection fraction (HFpEF) as an example, ejection fraction (EF) values are needed but they[…]

By Madelyn Wilson, Chief People Officer, OM1   |   March 29, 2023 As a leading health outcomes organization, our teams work in partnership with clients every day to measure, compare and predict treatment outcomes. Equity is increasingly at the forefront of many of our conversations, in both our client work and within our own workplace. Joining[…]